{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:23:59Z","timestamp":1755224639201,"version":"3.43.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Monash University RTP scholarship"},{"name":"National Health and Medical Research Council Postgraduate Scholarship"},{"name":"Crohn\u2019s Colitis Australia Postgraduate Scholarship"},{"name":"the National Health and Medical Research Council Investigator Grant Leadership 1"},{"name":"Fielding Foundation\u2019s Innovation Award and Fellowship"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Aims<\/jats:title>\n                  <jats:p>Inflammatory bowel disease (IBD) therapeutics and pregnancy itself are known to impact immune cell populations, but a detailed understanding of the effect of specific therapies is lacking, particularly for infants exposed in utero. With comprehensive flow cytometric assessment, we aimed to explore how IBD and its treatment impact both maternal and infant immunophenotypes and cytokine production.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Peripheral blood was taken for flow cytometry immunophenotyping and quantification of cytokine responses to stimulation from women with IBD and healthy controls throughout pregnancy, at delivery, and postpartum. Blood samples were also taken from the umbilical cord and peripherally from the resultant offspring at the age of 6 weeks.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Eighteen participants (16 with IBD and 2 healthy controls) were recruited to this single-center prospective cohort study. Basal T regulatory cell population proportions were 46% lower (0.21% vs 0.39%, P\u2005=\u2005.027) in those participants exposed to ustekinumab (n\u2005=\u20054). No other significant differences were noted in immunophenotype according to drug therapy exposure. Basal (1.75% vs 0.47%, P\u2005=\u2005.036) and lipopolysaccharide-stimulated (72.2% vs 64.7%, P\u2005=\u2005.028) production of tumour necrosis factor by classical dendritic cells were increased 3.7- and 1.1-fold, respectively, in those with an elevated fecal calprotectin (n\u2005=\u20056). Basal CD4+\u03b14\u03b27+ (41.4% to 66.5%, P\u2005=\u2005.0043) and CD8+\u03b14\u03b27+ (81.2% to 93.6%, P\u2005=\u2005.007) population proportions increased 1.6- and 1.2-fold, respectively, in infants from birth to 6 weeks.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study provides the foundation for ongoing investigation to more definitively extricate the impact of maternal IBD activity, drug exposures, and disease phenotype on infant immune system development and function. These novel data suggest that IBD pharmacotherapies may not significantly impact maternal or infant immune regulation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izaf052","type":"journal-article","created":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T08:50:05Z","timestamp":1746953405000},"page":"2204-2216","source":"Crossref","is-referenced-by-count":0,"title":["Innate and Adaptive Immunity is not Impacted by Inflammatory Bowel Disease Medications in Pregnant Women and Their Offspring"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4331-9295","authenticated-orcid":false,"given":"Ralley E","family":"Prentice","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, St Vincent\u2019s Hospital Melbourne , Melbourne, VIC ,","place":["Australia"]},{"name":"Department of Gastroenterology, Monash Health , Melbourne, VIC ,","place":["Australia"]},{"name":"Department of Medicine, Monash University , Melbourne, VIC ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven X","family":"Cho","sequence":"additional","affiliation":[{"name":"The Ritchie Centre, Hudson Institute of Medical Research , Melbourne, VIC ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally J","family":"Bell","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Monash Health , Melbourne, VIC ,","place":["Australia"]},{"name":"Department of Medicine, Monash University , Melbourne, VIC ,","place":["Australia"]},{"name":"Department of Medicine, University of Melbourne , Melbourne, VIC ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia A","family":"Nold-Petry","sequence":"additional","affiliation":[{"name":"The Ritchie Centre, Hudson Institute of Medical Research , Melbourne, VIC ,","place":["Australia"]},{"name":"Department of Medicine, University of Melbourne , Melbourne, VIC ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Lee","sequence":"additional","affiliation":[{"name":"The Ritchie Centre, Hudson Institute of Medical Research , Melbourne, VIC ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indiana","family":"Zorkau","sequence":"additional","affiliation":[{"name":"The Ritchie Centre, Hudson Institute of Medical Research , Melbourne, VIC ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Burns","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Monash Health , Melbourne, VIC ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily K","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St Vincent\u2019s Hospital Melbourne , Melbourne, VIC ,","place":["Australia"]},{"name":"Department of Medicine, University of Melbourne , Melbourne, VIC ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3911-4780","authenticated-orcid":false,"given":"Emma","family":"Flanagan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St Vincent\u2019s Hospital Melbourne , Melbourne, VIC ,","place":["Australia"]},{"name":"Department of Medicine, University of Melbourne , Melbourne, VIC ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel F","family":"Nold","sequence":"additional","affiliation":[{"name":"The Ritchie Centre, Hudson Institute of Medical Research , Melbourne, VIC ,","place":["Australia"]},{"name":"Department of Paediatrics, Monash University , Melbourne, VIC ,","place":["Australia"]},{"name":"Monash Newborn, Monash Children\u2019s Hospital , Melbourne, VIC ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimma","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Monash Health , Melbourne, VIC ,","place":["Australia"]},{"name":"Department of Medicine, Monash University , Melbourne, VIC ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"issue":"5","key":"2025081217443209700_CIT0001","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","article-title":"Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States","volume":"165","author":"Lewis","year":"2023","journal-title":"Gastroenterology."},{"issue":"1","key":"2025081217443209700_CIT0002","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjac115","article-title":"European Crohn\u2019s and colitis guidelines on sexuality, fertility, pregnancy, and lactation","volume":"17","author":"Torres","year":"2023","journal-title":"J Crohns Colitis."},{"issue":"4","key":"2025081217443209700_CIT0003","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1053\/j.gastro.2020.11.038","article-title":"Pregnancy and neonatal outcomes after fetal exposure to biologics and thiopurines among women with inflammatory bowel disease","volume":"160","author":"Mahadevan","year":"2021","journal-title":"Gastroenterology."},{"volume-title":"Infliximab Perscribing Information Reference ID: 4868076 2021:29","author":"Food and Drug Administration","key":"2025081217443209700_CIT0004"},{"issue":"6","key":"2025081217443209700_CIT0005","doi-asserted-by":"publisher","first-page":"535","DOI":"10.4161\/mabs.3.6.17815","article-title":"Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders","volume":"3","author":"Benson","year":"2011","journal-title":"mAbs"},{"issue":"4","key":"2025081217443209700_CIT0006","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1053\/gast.2001.27968","article-title":"Immune cell trafficking in uterus and early life is dominated by the mucosal addressin MAdCAM-1 in humans","volume":"121","author":"Salmi","year":"2001","journal-title":"Gastroenterology."},{"issue":"2","key":"2025081217443209700_CIT0007","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jcmgh.2021.03.012","article-title":"Deep analysis of the peripheral immune system in IBD reveals new insight in disease subtyping and response to monotherapy or combination therapy","volume":"12","author":"Kosoy","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol."},{"issue":"5","key":"2025081217443209700_CIT0008","doi-asserted-by":"publisher","first-page":"100631","DOI":"10.1016\/j.xcrm.2022.100631","article-title":"Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine","volume":"3","author":"Takano","year":"2022","journal-title":"Cell Rep Med"},{"issue":"2","key":"2025081217443209700_CIT0009","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1203\/01.PDR.0000104150.85437.FE","article-title":"Cellular immune response of fetuses to cytomegalovirus","volume":"55","author":"Elbou Ould","year":"2004","journal-title":"Pediatr Res."},{"issue":"639","key":"2025081217443209700_CIT0010","doi-asserted-by":"publisher","first-page":"eaaz8454","DOI":"10.1126\/scitranslmed.aaz8454","article-title":"Type 2 immune polarization is associated with cardiopulmonary disease in preterm infants","volume":"14","author":"Lao","year":"2022","journal-title":"Sci Transl Med."},{"issue":"3","key":"2025081217443209700_CIT0011","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/gutjnl-2019-318263","article-title":"Modulation of cytokine patterns and microbiome during pregnancy in IBD","volume":"69","author":"van der Giessen","year":"2020","journal-title":"Gut."},{"issue":"18","key":"2025081217443209700_CIT0012","doi-asserted-by":"publisher","first-page":"10281","DOI":"10.3390\/ijms231810281","article-title":"Elevated IL-6 and IL-22 in early pregnancy are associated with worse disease course in women with inflammatory bowel disease","volume":"23","author":"Wu","year":"2022","journal-title":"Int J Mol Sci ."},{"issue":"5","key":"2025081217443209700_CIT0013","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.cell.2018.06.045","article-title":"Stereotypic immune system development in newborn children","volume":"174","author":"Olin","year":"2018","journal-title":"Cell."},{"issue":"7","key":"2025081217443209700_CIT0014","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/apt.16294","article-title":"Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonates","volume":"53","author":"Flanagan","year":"2021","journal-title":"Aliment Pharmacol Ther."},{"issue":"6","key":"2025081217443209700_CIT0015","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/apt.16739","article-title":"Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero","volume":"55","author":"Flanagan","year":"2022","journal-title":"Aliment Pharmacol Ther."},{"issue":"10","key":"2025081217443209700_CIT0016","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1111\/apt.16102","article-title":"Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure","volume":"52","author":"Flanagan","year":"2020","journal-title":"Aliment Pharmacol Ther."},{"issue":"1","key":"2025081217443209700_CIT0017","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.gastro.2016.04.002","article-title":"Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection","volume":"151","author":"Julsgaard","year":"2016","journal-title":"Gastroenterology."},{"issue":"1","key":"2025081217443209700_CIT0018","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3389\/fimmu.2017.01123","article-title":"Immunological changes in blood of newborns exposed to anti-TNF-alpha during pregnancy","volume":"8","author":"Esteve-Sole","year":"2017","journal-title":"Frontline Immunol."},{"issue":"2","key":"2025081217443209700_CIT0019","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/jpc.15174","article-title":"Burden of infection in Australian infants","volume":"57","author":"Rowland","year":"2021","journal-title":"J Paediatr Child Health."},{"volume-title":"Australia\u2019s Mothers and Babies.","year":"2022","author":"Australian Institute of Health and Welfare","key":"2025081217443209700_CIT0020"},{"issue":"1","key":"2025081217443209700_CIT0021","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fimmu.2020.02025","article-title":"T Helper (Th) cell profiles in pregnancy and recurrent pregnancy losses: Th1\/Th2\/Th9\/Th17\/Th22\/Tfh Cells","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol."},{"issue":"9","key":"2025081217443209700_CIT0022","doi-asserted-by":"publisher","first-page":"e46241","DOI":"10.1371\/journal.pone.0046241","article-title":"Differential effects of IL-12 on Tregs and non-Treg T cells: roles of IFN-\u03b3, IL-2 and IL-2R","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One."},{"issue":"2","key":"2025081217443209700_CIT0023","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jri.2010.02.006","article-title":"Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice","volume":"85","author":"Shima","year":"2010","journal-title":"J Reprod Immunol."},{"issue":"1","key":"2025081217443209700_CIT0024","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.imlet.2014.06.013","article-title":"The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus","volume":"162","author":"La Rocca","year":"2014","journal-title":"Immunol Lett."},{"issue":"4","key":"2025081217443209700_CIT0025","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41581-022-00670-0","article-title":"The role of immune cells and mediators in preeclampsia","volume":"19","author":"Deer","year":"2023","journal-title":"Nat Rev Nephrol."},{"issue":"1","key":"2025081217443209700_CIT0026","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cgh.2024.01.008","article-title":"Infant ustekinumab clearance, risk of infection, and development after exposure during pregnancy","volume":"23","author":"Julsgaard","year":"2024","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"3","key":"2025081217443209700_CIT0027","doi-asserted-by":"publisher","first-page":"468-476","DOI":"10.14309\/ajg.0000000000002553","article-title":"Maternal and neonatal outcomes in vedolizumab and ustekinumab exposed pregnancies: results from the PIANO registry","volume":"119","author":"Chugh","year":"2023","journal-title":"Am J Gastroenterol."},{"issue":"1","key":"2025081217443209700_CIT0028","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cgh.2024.02.025","article-title":"Vedolizumab and ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero","volume":"23","author":"Prentice","year":"2024","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"9","key":"2025081217443209700_CIT0029","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S2352-4642(23)00136-0","article-title":"Immunological effects and safety of live rotavirus vaccination after antenatal exposure to immunomodulatory biologic agents: a prospective cohort study from the Canadian Immunization Research Network","volume":"7","author":"Fitzpatrick","year":"2023","journal-title":"Lancet Child Adolescent Health."},{"issue":"6","key":"2025081217443209700_CIT0030","doi-asserted-by":"publisher","first-page":"e00494","DOI":"10.14309\/ctg.0000000000000494","article-title":"Limited dose-dependent effects of vedolizumab on various leukocyte subsets","volume":"13","author":"Becker","year":"2022","journal-title":"Clin Transl Gastroenterol."},{"issue":"7","key":"2025081217443209700_CIT0031","doi-asserted-by":"publisher","first-page":"e0220008","DOI":"10.1371\/journal.pone.0220008","article-title":"Comparison of the integrin \u03b14\u03b27 expression pattern of memory T cell subsets in HIV infection and ulcerative colitis","volume":"14","author":"Wittner","year":"2019","journal-title":"PLoS One."},{"issue":"1","key":"2025081217443209700_CIT0032","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.placenta.2022.02.023","article-title":"Percentiles of intrauterine placental volume and placental volume relative to fetal volume: a prospective magnetic resonance imaging study","volume":"121","author":"Peterson","year":"2022","journal-title":"Placenta."},{"issue":"12","key":"2025081217443209700_CIT0033","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1002\/eji.200425223","article-title":"Functional involvement of P-selectin and MAdCAM-1 in the recruitment of alpha4beta7-integrin-expressing monocyte-like cells to the pregnant mouse uterus","volume":"34","author":"Fernekorn","year":"2004","journal-title":"Eur J Immunol."},{"issue":"8","key":"2025081217443209700_CIT0034","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/ibd\/izac056","article-title":"Vedolizumab antagonizes MAdCAM-1-dependent human placental cytotrophoblast adhesion and invasion in vitro","volume":"28","author":"Blaisdell","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"2","key":"2025081217443209700_CIT0035","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/pr.2011.26","article-title":"Neonatal T-cell maturation and homing receptor responses to Toll-like receptor ligands differ from those of adult naive T cells: relationship to prematurity","volume":"71","author":"Crespo","year":"2012","journal-title":"Pediatr Res."},{"issue":"7","key":"2025081217443209700_CIT0036","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.4049\/jimmunol.0901091","article-title":"Dynamic development of homing receptor expression and memory cell differentiation of infant CD4+CD25high regulatory T Cells1","volume":"183","author":"Grindebacke","year":"2009","journal-title":"J Immunol"},{"issue":"9","key":"2025081217443209700_CIT0037","doi-asserted-by":"crossref","first-page":"e75594","DOI":"10.1371\/journal.pone.0075594","article-title":"Neonatal mucosal immune stimulation by microbial superantigen improves the tolerogenic capacity of CD103+ dendritic cells","volume":"8","author":"Stern","year":"2013","journal-title":"PLoS One."},{"issue":"1","key":"2025081217443209700_CIT0038","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jcmgh.2023.03.005","article-title":"The effect of in utero exposure to maternal inflammatory bowel disease and immunomodulators on infant immune system development and function","volume":"16","author":"Prentice","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol."},{"issue":"10","key":"2025081217443209700_CIT0039","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1111\/apt.16593","article-title":"Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study","volume":"54","author":"Julsgaard","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"2025081217443209700_CIT0040","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41392-023-01653-8.","article-title":"\u03b3\u03b4 T cells: origin and fate, subsets, diseases and immunotherapy","volume":"8","author":"Hu","year":"2023","journal-title":"Signal Transduct Target Ther."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/8\/2204\/63142605\/izaf052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/8\/2204\/63142605\/izaf052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T21:44:40Z","timestamp":1755035080000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/31\/8\/2204\/8128507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,5,9]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaf052","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"type":"print","value":"1078-0998"},{"type":"electronic","value":"1536-4844"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,5,9]]}}}